Genomic Potential Suppliers In North America

Editas Medicine is a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around ...

Pierian guides healthcare organizations to develop NGS testing programs onsite and support their growth through our best-in-class technology and services. We partner with clinicians and medical facilities to advance clinical genomics and modernize ...